July 1, 2022
Biomarkers and algorithms are to enable minimally invasive and cost-effective early diagnosis of Alzheimer‘s disease Alzheimer‘s disease and related dementias are heterogeneous, multifactorial diseases in which several etiopathogenic mechanisms lead to neuronal cell death and loss of cognitive function.  The disease is believed to begin decades before diagnosis, posing a significant treatment challenge. Therefore, the...
Read More